Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age, year | 2.197 (1.177ā4.101) | 0.013 | 2.278 (1.172ā4.428) | 0.015 |
Sex | ||||
Ā Male/female | 0.848 (0.503ā1.429) | 0.535 | Ā | Ā |
TNM stage | ||||
Ā I/II/III/IV | 3.135 (2.280ā4.310) | <ā0.001 | Ā | Ā |
Tumor stage | ||||
Ā T1/T2/T3/T4 | 1.481 (1.074ā2.043) | 0.017 | 1.801 (1.293ā2.510) | 0.001 |
Node stage | ||||
Ā N0/N1/N2/N3 | 1.317 (1.019ā1.701) | 0.035 | Ā | Ā |
Metastasis | ||||
Ā No/yes | 4.753 (2.732ā8.268) | <ā0.001 | 5.164 (2.912ā9.157) | <ā0.001 |
Location | ||||
Ā 1/2/3/4 | 0.958 (0.732ā1.254) | 0.757 | Ā | Ā |
AST, U/L | ||||
Ā ā¤ā22.8/>ā22.8 | 1.511 (0.934ā2.446) | 0.093 | Ā | Ā |
ALT, U/L | ||||
Ā ā¤ā30.1/>ā30.1 | 0.558 (0.267ā1.168) | 0.122 | Ā | Ā |
LDH, U/L | ||||
Ā ā¤ā168.7/>ā168.7 | 2.026 (1.252ā3.281) | 0.004 | Ā | Ā |
GGT, U/L | ||||
Ā ā¤ā26.9/>ā26.9 | 3.157 (1.929ā5.167) | 0.001 | 2.093 (1.223ā3.581) | 0.007 |
TBA, μmol/L | ||||
Ā ā¤ā5.4/>ā5.4 | 2.065 (1.277ā3.339) | 0.003 | Ā | Ā |
ALP, U/L | ||||
Ā ā¤ā80/>ā80 | 3.393 (2.093ā5.499) | <ā0.001 | 2.161 (1.271ā3.672) | 0.004 |
ALB, g/L | ||||
Ā ā¤ā38.8/>ā38.8 | 0.541 (0.316ā0.837) | 0.007 | Ā | Ā |
TBIL, μmol/L | ||||
Ā ā¤ā7.3/>ā7.3 | 0.623 (0.369ā1.053) | 0.077 | Ā | Ā |
ApoA1, g/L | ||||
Ā ā¤ā1.1/>ā1.1 | 0.564 (0.243ā1.309) | 0.182 | Ā | Ā |
ApoB, g/L | ||||
Ā ā¤ā1.1/>ā1.1 | 2.056 (1.101ā3.841) | 0.024 | Ā | Ā |
PT, S | ||||
Ā ā¤ā11.9/>ā11.9 | 1.464 (0.886ā2.419) | 0.137 | Ā | Ā |
Fbg, g/L | ||||
Ā ā¤ā3.6/>ā3.6 | 1.876 (1.052ā3.346) | 0.033 | Ā | Ā |